Ken Fisher Biomarin Pharmaceutical Inc Transaction History
Fisher Asset Management, LLC
- $271 Billion
- Q3 2025
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 31,726 shares of BMRN stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,726
Previous 13,545
134.23%
Holding current value
$1.74 Million
Previous $744,000
130.91%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BMRN
# of Institutions
667Shares Held
182MCall Options Held
1.48MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...